Julie Mallory Crawford

By Ewa J. Kleczyk, Julie Mallory Crawford and Laura Dalfonso

This chapter discusses the current landscape of Atopic Dermatitis treatment pathways and management of disease progression. Data leveraged for these types of analyses can come from disease-based communities, otherwise known as patient registries. Disease-based communities can work with participating healthcare institutions and enroll qualified patients to aid understanding of the population and sub-cohorts’ characteristics, as well as therapy protocols and regimens, time to and on therapy, discontinuation trends and reasons, and healthcare outcomes. Since the data collection includes Electronic Healthcare Records (EHRs) with the ability to append patient reported outcome questionnaires, as well as any other data sources relevant to the condition being studied, the resulting datasets provide in-depth insights on the patient population and their treatment pathways. Treating physicians are the Principal Investigators, managing and monitoring the patients’ progression and treatment. The reader is able, as a result, to learn the current preferred treatment pathways in treating Atopic Dermatitis, management of disease progression, as well as understand the underlying patient characteristics and historical medical information that drive the selection of therapies.

Part of the book: Latest Breakthroughs in the Treatment of Atopic Dermatitis